Home > Pancreas Diseases and Treatments > Diseases of the Pancreas > Pancreatic Cancer > Clinical Trials > Clinical Trial Phases

Clinical Trial Phases

Cancer Basics
Endocrine Tumors
Exocrine Tumors
Risk Factors
Genetics
Symptoms
Detection and Diagnosis
Staging
Treatment
Clinical Trials
- Clinical Trial Phases
- Clinical Trial Participation
Coping

Clinical trials are conducted in phases. Each phase of a trial has a different purpose and helps scientists to answer specific questions.

While small, early phase trials may be conducted by individuals or small groups of physicians, larger trials are typically conducted by hospitals, pharmaceutical companies, or device manufacturers. If a therapy successfully passes through phase III trials, the FDA may approve it to be marketed to the public.

Phase	Definition
Phase I Trials	Researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase II Trials	The study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
Phase III Trials	The study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase IV Trials	Post-marketing studies delineate additional information including the drug's risks, benefits, and optimal use.

< Previous: Clinical Trials

Next: Clinical Trial Participation >

APPOINTMENT CENTER

What to expect from an appointment with a specialist:

Appointment Request Form
Directions to the Center